atrasentan has been researched along with cyclosporine in 3 studies
| Studies (atrasentan) | Trials (atrasentan) | Recent Studies (post-2010) (atrasentan) | Studies (cyclosporine) | Trials (cyclosporine) | Recent Studies (post-2010) (cyclosporine) |
|---|---|---|---|---|---|
| 358 | 41 | 108 | 30,547 | 3,802 | 6,558 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Opgenorth, TJ; Polakowski, JS; Pollock, DM; Pollock, JS | 1 |
| El-Din, MM; El-Mas, MM; Elmallah, AI; Khedr, MM; Nasser, SA; Sabra, R | 2 |
3 other study(ies) available for atrasentan and cyclosporine
| Article | Year |
|---|---|
Role of endothelin ET(A) receptors in the hypertension produced by 4-day L-nitroarginine methyl ester and cyclosporine treatment.
Topics: Animals; Atrasentan; Cyclosporine; Drinking Behavior; Endothelin Receptor Antagonists; Enzyme Inhibitors; Feeding Behavior; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptors, Endothelin | 1998 |
Blockade of endothelin ET(A), but not thromboxane, receptors offsets the cyclosporine-evoked hypertension and interrelated baroreflex and vascular dysfunctions.
Topics: Animals; Atrasentan; Blood Pressure; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Heart Rate; Hypertension; Male; Naphthalenes; Nitric Oxide; Nitric Oxide Synthase Type III; Propionates; Pyrrolidines; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptors, Thromboxane; Signal Transduction; Time Factors; Vasodilation; Vasodilator Agents | 2014 |
Facilitation by the renin-angiotensin system of cyclosporine-evoked hypertension in rats: Role of arterial baroreflexes and vasoreactivity.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Angiotensin II; Animals; Aorta; Atrasentan; Baroreflex; Blood Pressure; Captopril; Cyclosporine; Hypertension; Indomethacin; Losartan; Male; Naphthalenes; Nitric Oxide Synthase Type III; Nitroprusside; Oligopeptides; Phenylephrine; Piperidines; Propionates; Pyrrolidines; Rats; Renin-Angiotensin System; Vasoconstriction; Vasodilation | 2016 |